HIPK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.13170028903653E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.55480003819031E-09 |
Normal-vs-Stage2 |
1.52034999999495E-05 |
Normal-vs-Stage3 |
1.66247999999758E-05 |
Normal-vs-Stage4 |
2.41679999999356E-05 |
Stage1-vs-Stage2 |
8.623200E-01 |
Stage1-vs-Stage3 |
6.242000E-01 |
Stage1-vs-Stage4 |
4.597200E-01 |
Stage2-vs-Stage3 |
8.131800E-01 |
Stage2-vs-Stage4 |
3.791000E-01 |
Stage3-vs-Stage4 |
3.107600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.12900030938101E-10 |
Normal-vs-AfricanAmerican |
3.87449999861289E-08 |
Normal-vs-Asian |
9.416000E-04 |
Caucasian-vs-AfricanAmerican |
7.776600E-01 |
Caucasian-vs-Asian |
6.854600E-01 |
AfricanAmerican-vs-Asian |
6.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.80377934810849E-12 |
Normal-vs-Female |
1.621330E-04 |
Male-vs-Female |
9.475600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.02090000009269E-07 |
Normal-vs-Extreme_Weight |
4.77899941841997E-11 |
Normal-vs-Obese |
9.31610000032279E-07 |
Normal-vs-Extreme_Obese |
1.71893999999506E-05 |
Normal_Weight-vs-Extreme_Weight |
5.344200E-01 |
Normal_Weight-vs-Obese |
1.698180E-01 |
Normal_Weight-vs-Extreme_Obese |
6.330600E-01 |
Extreme_Weight-vs-Obese |
1.862200E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.816600E-01 |
Obese-vs-Extreme_Obese |
1.659020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.903200E-03 |
Normal-vs-Age(41-60Yrs) |
3.1432000000553E-06 |
Normal-vs-Age(61-80Yrs) |
1.99840144432528E-15 |
Normal-vs-Age(81-100Yrs) |
6.30639999998905E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.280400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.369960E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.461500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.842300E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.287700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.319400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.99410488121998E-11 |
Normal-VS-Type2 PRCC |
2.72379996335559E-09 |
Normal-VS-KIRP CIMP |
2.406400E-02 |
Normal-VS-Unclassified PRCC |
3.637300E-03 |
Type1 PRCC-VS-Type2 PRCC |
7.652800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.135040E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.239700E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.532380E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.172300E-02 |
KIRP CIMP-VS-Unclassified PRCC |
9.909600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.58599808233839E-11 |
Normal-vs-N1 |
2.03059999999144E-05 |
Normal-vs-N2 |
5.239200E-03 |
N0-vs-N1 |
1.976990E-01 |
N0-vs-N2 |
9.771200E-01 |
N1-vs-N2 |
5.859400E-01 |
|
|